Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut, U.S.A.
Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut, U.S.A..
Arthroscopy. 2019 Mar;35(3):770-774. doi: 10.1016/j.arthro.2018.09.019. Epub 2019 Jan 21.
To validate the Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10 for patients who have lateral epicondylitis requiring surgical treatment in comparison with other gold standard patient-reported outcomes.
Sixty-two patients with lateral epicondylitis of the elbow were prospectively enrolled before arthroscopic treatment. Inclusion criteria were patients 18 years of age or older with a diagnosis of lateral epicondylitis. Each patient completed the PROMIS Global-10, EuroQol 5 Dimension (EQ-5D), American Shoulder and Elbow Surgeons (ASES) assessment form, Mayo Elbow Performance Score (MEPS), and Quick Disabilities of the Arm, Shoulder and Hand Score (QuickDASH). Spearman correlations were calculated. Bland-Altman agreement tests were conducted between estimated EQ-5D scores from the PROMIS-10 and actual EQ-5D scores.
Correlation between the PROMIS-10 and the EQ-5D was excellent (0.72, P < .0001). Bland-Altman 95% limits of agreement for estimated EQ-5D scores ranged from 0.33 below to 0.21 above actual EQ-5D scores. Correlation of the PROMIS-10 physical score was good to excellent with MEPS (0.61, P < .0001) and QuickDASH scores (0.64, P < .0001) and good with the ASES (0.58, P < .0001). Correlation of the PROMIS mental scores was good with QuickDASH (0.50, P < .0001) and poor with ASES (0.26, P = .0492) and MEPS (0.37, P = .0038).
The PROMIS Global-10 physical scores showed good to excellent correlation with gold standard patient-reported outcome instruments, demonstrating it is a reliable tool for outcome assessment in populations with lateral epicondylitis. Despite the excellent correlation with the EQ-5D, the 95% limit of agreement and high variability among the estimated EQ-5D scores derived from the PROMIS-10 suggests that the PROMIS-10 cannot be used as a substitute for actual EQ-5D scores to derive quality-adjusted life years for economic evaluations and cost-effectiveness research.
Level II, development of diagnostic criteria on the basis of consecutive patients.
与其他金标准患者报告结局相比，验证用于需要手术治疗的外侧肱骨髁炎患者的患者报告结局测量信息系统（PROMIS）全球-10。
在关节镜治疗前，前瞻性纳入 62 例肘外侧肱骨髁炎患者。纳入标准为年龄 18 岁或以上，诊断为外侧肱骨髁炎。每位患者均完成 PROMIS 全球-10、欧洲五维健康量表（EQ-5D）、美国肩肘外科医师协会（ASES）评估表、梅奥肘功能评分（MEPS）和快速残疾的手臂、肩和手评分（QuickDASH）。计算 Spearman 相关系数。进行了从 PROMIS-10 估算的 EQ-5D 评分与实际 EQ-5D 评分之间的 Bland-Altman 一致性检验。
PROMIS-10 与 EQ-5D 之间的相关性非常好（0.72，P<.0001）。Bland-Altman 95%置信区间估计的 EQ-5D 评分范围从实际 EQ-5D 评分低 0.33 到高 0.21。PROMIS-10 生理评分与 MEPS（0.61，P<.0001）和 QuickDASH 评分（0.64，P<.0001）的相关性较好，与 ASES（0.58，P<.0001）的相关性较好。PROMIS 心理评分与 QuickDASH（0.50，P<.0001）的相关性较好，与 ASES（0.26，P=.0492）和 MEPS（0.37，P=.0038）的相关性较差。
PROMIS 全球-10 生理评分与金标准患者报告结局工具具有良好至极好的相关性，表明它是评估外侧肱骨髁炎人群结局的可靠工具。尽管与 EQ-5D 具有极好的相关性，但从 PROMIS-10 得出的估计 EQ-5D 评分的 95%置信区间和高变异性表明，PROMIS-10 不能替代实际的 EQ-5D 评分，无法为经济评估和成本效益研究得出质量调整生命年。
基于连续患者的诊断标准制定的二级水平。
